Pangea Bio
3 known investors
Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. The company serves patients with neurological and mental health conditions.
Investors · 3
Frequently asked questions
- What does Pangea Bio do?
- Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. The company serves patients with neurological and mental health conditions.
- Who are Pangea Bio's investors?
- Pangea Bio's investors include Metaplanet, Vox Capital, XEIA Venture Partners.